Reuters logo
BRIEF-Seattle Genetics reports 8.2 percent stake in Immunomedics as of June 29, 2017
July 7, 2017 / 9:20 PM / in 5 months

BRIEF-Seattle Genetics reports 8.2 percent stake in Immunomedics as of June 29, 2017

July 7 (Reuters) - Seattle Genetics Inc:

* Seattle genetics inc reports a 8.2 percent stake in immunomedics inc as of June 29, 2017 - sec filing

* Seattle Genetics- acquired common stock, warrant in connection with development, license agreement with issuer to acquire strategic interest in Immunomedics Source text (bit.ly/2tyWqBp) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below